A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of a Single Infusion of Bezlotoxumab (MK-6072, Human Monoclonal Antibody to C. difficile Toxin B) in Children Aged 1 to
Administered By
Awarded By
Contributors
- Kelly, Matthew Principal Investigator
Start/End
- July 3, 2018 - July 31, 2022